Alphatec defends spinal partner Parcell Labs on FDA inquiry July 25, 2011 By MassDevice staff Leave a Comment Alphatec Holdings Inc. (NSDQ:ATEC) subsidiary Alphatec Spine responded to the FDA’s Untitled Letter challenging the status of the PureGen stem cell-based bone regeneration product developed with partner Parcell Laboratories.